US Stock MarketDetailed Quotes

MREO Mereo BioPharma

Watchlist
  • 3.9300
  • +0.0500+1.29%
Trading Jul 22 13:25 ET
600.51MMarket Cap-26200P/E (TTM)

Mereo BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Mereo BioPharma Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.05

+50.00%
Analyst Rating

Strong Buy

Jun 30, 2024

Mereo BioPharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: GBP

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2022/Q4-- / 0.000--
--2022/Q3-- / 0.000--
--2022/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2022/Q4-- / 0.000--
--2022/Q3-- / 0.000--
--2022/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Mereo BioPharma Earnings Reports

  • Mereo BioPharma | 10-Q: Quarterly report

    May 15 16:29 ET

  • Mereo BioPharma | 10-K: Annual report

    Mar 27 17:25 ET

  • Mereo BioPharma | 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 20, 2023 16:03 ET

  • Mereo BioPharma | 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 7, 2023 07:37 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg